drugset / Trial / NCT00793234
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and efficacy of a single administration of TB-402 for the prevention of VTE in patients undergoing knee replacement surgery.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-01
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Subject | TB-402 | Monoclonal antibody | 0.3 mg/kg | Intravenous |
| Subject | TB-402 | Monoclonal antibody | 0.6 mg/kg | Intravenous |
| Subject | TB-402 | Monoclonal antibody | 1.2 mg/kg | Intravenous |
Indications
No indication recorded.